Journal rankings · indicator year 2005
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2005
Immunology journal rankings 2005
64 ranked journals · Subfield in Immunology and Microbiology
Immunology has 64 ranked journals in 2005. The median journal has an OJR of 0.88, below the world average of 1.00, up 0.05 on 2004; Q1 starts at OJR 1.25. The top three are Nature Immunology, The Journal of Experimental Medicine, and Immunity.
Ranks and citation indicators: 2005. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2002–2004, the window the 2005 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Immunology and Microbiology (5)
64 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2004. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2002–2004, the window the 2005 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2002–2004 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2005. | Compare |
|---|---|---|---|---|---|---|---|
1Nature ImmunologyNature Portfolio · United States | 5.06Q1 | 17.33 0.16 up from 2004 | 715 | 20% | $12,690 | ||
2The Journal of Experimental MedicineRockefeller University Press · United States | 4.82Q1 | 14.85 0.81 down from 2004 | 1,034 | 99% | — | ||
3ImmunityCell Press · United States | 4.73Q1 | 14.30 2.52 down from 2004 | 495 | 97% | $10,400 | ||
4Annual Review of ImmunologyAnnual Reviews · United States | 3.01Q1 | 42.16 14.95 down from 2004 | 104 | 15% | — | ||
5Journal of Allergy and Clinical ImmunologyElsevier BV · United States | 2.35Q1 | 6.88 0.49 up from 2004 | 1,402 | 47% | $4,900 | ||
6Seminars in ImmunologyElsevier BV · United States | 2.29Q1 | 8.20 2.45 up from 2004 | 153 | 7% | $4,370 | ||
7The Journal of ImmunologyAmerican Association of Immunologists · United States | 2.12Q1 | 7.13 0.13 down from 2004 | 5,195 | 52% | $3,500 | ||
8Nature reviews. ImmunologyNature Portfolio · United Kingdom | 1.63Q1 | 11.42 0.96 down from 2004 | 717 | 6% | — | ||
9European Journal of ImmunologyWiley · Germany | 1.62Q1 | 5.27 0.05 up from 2004 | 1,245 | 60% | $4,550 | ||
10Genes and ImmunitySpringer Nature · United States | 1.51Q1 | 3.83 0.36 down from 2004 | 314 | 9% | $3,190 | ||
11Journal of Leukocyte BiologyOxford University Press · United States | 1.51Q1 | 4.94 0.52 up from 2004 | 835 | 13% | $3,800 | ||
12International ImmunologyOxford University Press · United Kingdom | 1.36Q1 | 4.29 0.45 up from 2004 | 495 | 40% | $3,530 | ||
13Springer Seminars in ImmunopathologySpringer Science+Business Media · Germany | 1.35Q1 | 3.79 1.84 up from 2004 | 94 | 12% | — | ||
14International Reviews of ImmunologyTaylor & Francis · United States | 1.27Q1 | 2.65 0.28 down from 2004 | 76 | 3% | — | ||
15Molecular ImmunologyElsevier BV · Netherlands | 1.26Q1 | 3.60 0.11 up from 2004 | 610 | 6% | $3,340 | ||
16Critical Reviews in ImmunologyBegell House · United States | 1.25Q1 | 3.64 0.40 down from 2004 | 68 | 7% | — | ||
17Journal of Reproductive ImmunologyElsevier BV · Netherlands | 1.24Q2 | 2.63 0.78 down from 2004 | 195 | 5% | $3,690 | ||
18Clinical ImmunologyElsevier BV · Netherlands | 1.22Q2 | 3.24 0.10 down from 2004 | 487 | 8% | $4,400 | ||
19Clinical Reviews in Allergy & ImmunologySpringer Nature · United States | 1.21Q2 | 2.88 0.62 up from 2004 | 122 | 3% | $5,490 | ||
20Journal of Clinical ImmunologySpringer Science+Business Media · United States | 1.19Q2 | 3.30 0.80 up from 2004 | 181 | 12% | $4,990 | ||
21Clinical & Experimental ImmunologyOxford University Press · United Kingdom | 1.11Q2 | 3.21 0.47 up from 2004 | 968 | 99% | $3,816 | ||
22ImmunologyWiley · United Kingdom | 1.11Q2 | 3.29 0.17 up from 2004 | 674 | 50% | $5,330 | ||
23BMC ImmunologyOABioMed Central · United Kingdom | 1.11Q2 | 2.84 0.28 down from 2004 | 48 | 100% | $3,090 | ||
24Journal of Immunological MethodsElsevier BV · Netherlands | 1.10Q2 | 2.86 0.09 down from 2004 | 785 | 7% | $2,970 | ||
25BioDrugsAdis, Springer Healthcare · Switzerland | 1.07Q2 | 2.45 0.13 up from 2004 | 122 | 3% | $5,190 | ||
26Expert Opinion on Biological TherapyTaylor & Francis · United Kingdom | 1.06Q2 | 3.03 0.31 up from 2004 | 359 | 6% | — | ||
27ImmunogeneticsSpringer Science+Business Media · Germany | 1.04Q2 | 3.49 0.04 down from 2004 | 338 | 18% | $2,890 | ||
28Developmental & Comparative ImmunologyElsevier BV · United Kingdom | 0.96Q2 | 3.41 0.86 up from 2004 | 318 | 12% | $3,340 | ||
29Journal of AutoimmunityElsevier BV · United Kingdom | 0.94Q2 | 2.78 0.64 up from 2004 | 235 | 5% | $5,420 | ||
30Scandinavian Journal of ImmunologyWiley · United Kingdom | 0.94Q2 | 2.30 0.09 up from 2004 | 469 | 61% | $4,480 | ||
31Immunology and Cell BiologyWiley · Australia | 0.91Q2 | 2.16 0.74 down from 2004 | 233 | 13% | $3,750 | ||
32Human ImmunologyElsevier BV · United States | 0.89Q2 | 2.33 0.55 down from 2004 | 491 | 3% | $3,600 | ||
33CytokineElsevier BV · United Kingdom | 0.86Q3 | 2.17 0.01 up from 2004 | 469 | 5% | $3,220 | ||
34Trends in ImmunologyElsevier BV · United Kingdom | 0.86Q3 | 9.42 2.21 up from 2004 | 494 | 8% | $7,030 | ||
35Immunologic ResearchSpringer Science+Business Media · United States | 0.85Q3 | 2.63 0.24 up from 2004 | 173 | 5% | $2,890 | ||
36Journal of Interferon & Cytokine ResearchMary Ann Liebert, Inc. · United States | 0.81Q3 | 1.94 0.67 down from 2004 | 323 | 6% | — | ||
37Veterinary Immunology and ImmunopathologyElsevier BV · Netherlands | 0.79Q3 | 1.64 0.34 down from 2004 | 548 | 5% | $3,250 | ||
38Immunology LettersElsevier BV · Netherlands | 0.76Q3 | 2.20 0.09 down from 2004 | 648 | 8% | $3,290 | ||
39Journal of Endotoxin ResearchManey Publishing · United Kingdom | 0.75Q3 | 2.48 0.64 up from 2004 | 262 | 20% | — | ||
40Tissue AntigensWiley · United Kingdom | 0.73Q3 | 3.20 1.05 up from 2004 | 515 | 6% | — | ||
41Cytokine & Growth Factor ReviewsElsevier BV · United Kingdom | 0.68Q3 | 8.96 0.36 down from 2004 | 144 | 14% | $4,900 | ||
42Cellular ImmunologyElsevier BV · Netherlands | 0.68Q3 | 1.66 0.37 down from 2004 | 301 | 2% | $3,550 | ||
43Toxicologic PathologySAGE Publishing · United States | 0.64Q3 | 1.37 0.32 down from 2004 | 437 | 23% | $4,150 | ||
44Current Opinion in ImmunologyElsevier BV · United Kingdom | 0.63Q3 | 8.72 2.32 down from 2004 | 371 | 10% | $4,410 | ||
45American Journal of Reproductive ImmunologyWiley · United Kingdom | 0.63Q3 | 1.84 0.18 up from 2004 | 377 | 11% | $4,460 | ||
46Journal of Fish DiseasesWiley · United Kingdom | 0.60Q3 | 1.95 0.34 up from 2004 | 259 | 12% | $5,450 | ||
47Immunological ReviewsWiley · United States | 0.60Q3 | 9.70 0.55 up from 2004 | 306 | 8% | $5,000 | ||
48Drugs in R&DOAAdis, Springer Healthcare · New Zealand | 0.59Q3 | 1.14 0.26 up from 2004 | 123 | 0% | $3,490 | ||
49Fish & Shellfish ImmunologyElsevier BV · United Kingdom | 0.57Q4 | 2.41 0.42 up from 2004 | 286 | 5% | $4,330 | ||
50ImmunobiologyOAElsevier BV · Germany | 0.52Q4 | 1.35 0.33 down from 2004 | 225 | 11% | $2,840 |
Subfields of Immunology and Microbiology, with Immunology highlighted.
Journals
Citations made in 2005. Corpus-wide, 70.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
17 additional Immunology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2002–2004, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2005. Publication window: 2002–2004. How these summaries are calculated
- Ranked journals
- 64
- Window papers (baseline)
- 44,849 +18.1% from indicator year 2002
- Median OJR
- 0.88 +5.1% from indicator year 2002
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2002–2004 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 56 | 59 | 63 | 65 | 62 | 64 | 68 | 72 | 71 | 74 | 76 | 79 | 81 | 86 | 83 | 88 | 90 | 96 | 94 | 90 | 92 | 87 | 88 | 88 | 88 | 86 | |
| Window papers (baseline) | 33,673 | 35,811 | 37,963 | 40,362 | 42,065 | 44,849 | 47,600 | 50,960 | 53,923 | 57,726 | 63,072 | 65,596 | 67,601 | 67,579 | 70,684 | 72,624 | 73,354 | 72,790 | 72,098 | 72,447 | 74,045 | 77,362 | 81,615 | 83,779 | 84,353 | 84,391 | |
| Median OJR | 0.72 | 0.78 | 0.834 | 0.82 | 0.830 | 0.88 | 0.89 | 0.959 | 1.002 | 1.15 | 1.100 | 1.09 | 1.096 | 1.04 | 1.08 | 1.06 | 1.05 | 0.95 | 0.921 | 0.970 | 0.931 | 0.932 | 0.967 | 0.956 | 0.922 | 0.87 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.